Liminatus Pharma, Inc. · NASDAQ:LIMN
Liminatus Pharma, Inc. shareholders
As of Jun 30, 2026, 11 institutions reported holding Liminatus Pharma, Inc., 0.92% of its shares. Largest: XTX Topco Ltd, Geode Capital and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Liminatus Pharma, Inc. | Change | Filed |
|---|---|---|---|---|
| XTX Topco Ltd | 222K | 0.33% | new | Aug 14, 2026 |
| Geode Capital | 138K | 0.21% | +20,635 | Aug 12, 2026 |
| Vanguard | 86,572 | 0.13% | −21,558 | Aug 13, 2026 |
| Citadel | 56,089 | 0.08% | −621K | Aug 14, 2026 |
| Goldman Sachs | 40,220 | 0.06% | new | Aug 14, 2026 |
| StoneX Group Inc. | 26,058 | 0.04% | new | Aug 12, 2026 |
| State Street | 19,000 | 0.03% | no change | Aug 7, 2026 |
| UBS | 16,730 | 0.02% | −37,848 | Aug 13, 2026 |
| Tower Research Capital LLC (TRC) | 7,093 | 0.01% | −474 | Aug 11, 2026 |
| Barclays | 4,290 | <0.01% | new | Aug 14, 2026 |